BamSEC and AlphaSense Join Forces
Learn More

Harrow Inc Com – Material Contracts

NASDAQ: HROW    
Share price (5/22/26): $33.00    
Market cap (5/22/26): $1.230 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 34 pages $50,000,000 Harrow, Inc. 8.625% Senior Notes Due 2030 Purchase Agreement
12/34/56
EX-10.30
from 10-K 9 pages Consulting Agreement
12/34/56
EX-10.29
from 10-K 6 pages First Amendment to License Agreement
12/34/56
EX-10.28
from 10-K 49 pages License Agreement
12/34/56
EX-10.21
from 10-K 2 pages First Amendment to License and Supply Agreement
12/34/56
EX-10.15
from 10-K 1 page Material contract
12/34/56
EX-10.1
from 8-K ~5 pages Information Start Date January 30, 2026 Manager Mark L. Baum Location Remote Annualized Base Compensation Salary Amount $425,000 40% of Paid Base Compensation Annual Target Bonus While No Bonus Payment Is Guaranteed, Your Bonus Will Be Based on the Achievement of Targets Agreed Upon by You and Mr. Baum. You Must Be Employed With Harrow on the Day of Payment to Receive a Bonus Payment. Title, Compensation, and Options Will Be Reviewed Accordingly at the End of 2025. Fsla Exempt
12/34/56
EX-10.1
from 10-Q 2 pages Material contract
12/34/56
EX-10.1
from 8-K/A 7 pages Milestone Payment Agreement
12/34/56
EX-10.1
from 8-K 34 pages $250,000,000 Harrow, Inc. 8.625% Senior Notes Due 2030 Purchase Agreement
12/34/56
EX-10.4
from 10-Q 6 pages Harrow, Inc. 2025 Incentive Stock and Awards Plan Notice of Restricted Stock Unit Award
12/34/56
EX-10.3
from 10-Q 6 pages Harrow, Inc. 2025 Incentive Stock and Awards Plan Form of Nonqualified Stock Option Agreement
12/34/56
EX-10.2
from 10-Q 6 pages Harrow, Inc. 2025 Incentive Stock and Awards Plan Incentive Stock Option Agreement
12/34/56
EX-10.45
from 10-K 2 pages Material contract
12/34/56
EX-10.46
from 10-K 5 pages Third Amendment to License and Supply Agreement
12/34/56
EX-10.2
from 10-Q 2 pages Second Amendment to License and Supply Agreement
12/34/56
EX-10.1
from 8-K 53 pages Asset Purchase Agreement by and Among Novartis Technology LLC and Novartis Innovative Therapies AG and Harrow Health, Inc., Harrow Eye, LLC and Harrow Ip, LLC Dated as of December 13, 2022
12/34/56
EX-10.3
from 10-Q 3 pages Mutual Termination of the Agreement: The Parties Agree That, Effective on the Mutual Termination Effective Date, the Agreement Shall Be Deemed Terminated by the Mutual Agreement of the Parties. the Parties Further Agree as Follows
12/34/56
EX-10.1
from 10-Q 42 pages Recitals
12/34/56
EX-10.51
from 10-K 41 pages Asset Purchase Agreement by and Between Novartis Technology LLC and Novartis Ophthalmics AG and Harrow Health, Inc. Dated as of 17 December, 2021
12/34/56